Corvus Pharmaceuticals, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2025 Annual Meeting of Stockholders held on June 12, 2025. The record date for the meeting was April 17, 2025, with 68,169,461 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and stockholder voting outcomes.
Material Changes and Voting Results
Stockholders voted on three proposals with 53,395,500 shares voted in person or by proxy:
- Proposal 1 (Election of Directors): Class III nominees Ian T. Clark and Peter A. Thompson, M.D. were elected. Peter A. Thompson received significantly more "For" votes (38,832,016) compared to Ian T. Clark (28,853,180), with Clark facing higher "Votes Withheld" (10,420,373).
- Proposal 2 (Ratification of Auditors): Stockholders ratified the selection of PricewaterhouseCoopers LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The vote was 53,137,052 For, 117,988 Against, and 140,460 Abstain.
- Proposal 3 (Executive Compensation): Stockholders approved the non-binding advisory vote on executive compensation. The vote was 37,113,137 For, 2,096,601 Against, and 63,815 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on business outlook, specific risks, contingencies, or unusual items beyond the standard voting results.
Investor Verification Checklist
- Verify the specific reasons for the higher number of votes withheld for director nominee Ian T. Clark compared to Peter A. Thompson.
- Review the Definitive Proxy Statement on Schedule 14A filed on April 25, 2025, for detailed background on the director nominees and executive compensation rationale.
- Confirm the total number of broker non-votes (14,121,947) and their impact on the quorum and voting thresholds.